
Glucophage is the brand name for metformin, a common medicine for type 2 diabetes. It may help some people lose a small amount of weight or avoid weight gain, but it is not mainly a weight-loss drug.
Weight loss with metformin is usually gradual and modest. It works best when combined with healthy eating, physical activity, blood sugar monitoring, and the diabetes plan prescribed by your doctor.
Do not start, stop, or increase Glucophage only for weight loss without medical advice, especially if you have kidney disease, liver disease, heavy alcohol use, dehydration, or stomach illness.
Written by: Dr. Albana Greca, MD, MMedSc, Family Physician and Medical Author.
Medically reviewed by: Dr. Ruden Cakoni, MD, Endocrinologist.
Last reviewed: July 2026.
Many people with type 2 diabetes ask whether Glucophage causes weight loss. The answer is: sometimes, but not in the same way as modern weight-loss medicines. Glucophage mainly improves blood sugar control and insulin sensitivity. Weight improvement may happen as a helpful secondary effect.
Glucophage is a brand name for metformin. Metformin is commonly prescribed for type 2 diabetes and insulin resistance. It helps lower blood sugar mainly by reducing how much glucose the liver releases and by helping the body respond better to insulin.
Unlike some diabetes medicines, metformin usually does not cause weight gain. This is one reason it is often used in people with type 2 diabetes who also have overweight, obesity, or insulin resistance.
Helpful page: Glucophage side effects.
Some people lose weight while taking Glucophage, but the effect is usually mild to moderate and gradual. Other people may not lose weight, but may notice that weight gain becomes easier to control.
The result depends on your starting weight, food choices, activity level, insulin resistance, other medicines, dose, stomach tolerance, sleep, stress, and how consistently the medicine is taken.
It is better to think of Glucophage as a medicine that may support weight control, not as a medicine that automatically causes fat loss.
Glucophage may support weight control through several mechanisms:
These effects are not strong enough to replace healthy eating and movement. They work best as part of a complete diabetes care plan.
Helpful page: what is insulin resistance?
Not everyone loses weight on Glucophage. Some people lose a few pounds, some maintain their weight, and some do not notice a clear change.
Weight loss is more likely when metformin is combined with:
Helpful resource: foods and drinks for diabetes blood sugar control.
Weight loss, if it happens, is usually gradual. Many people do not notice major changes in the first few days or weeks. More realistic changes may appear after several weeks to a few months.
Rapid weight loss is not the goal. In type 2 diabetes, even modest weight loss can improve blood sugar, blood pressure, cholesterol, fatty liver risk, and insulin resistance when it is achieved safely.
If you are losing weight quickly without trying, or if weight loss comes with nausea, vomiting, poor appetite, weakness, or high blood sugar symptoms, contact your doctor.
Glucophage should not be used only for cosmetic weight loss. It is a diabetes and insulin-resistance medicine, and it should be used only when prescribed by a healthcare provider.
If weight is the main concern, your doctor may discuss nutrition therapy, physical activity, sleep, obesity-related conditions, and other medications that are specifically approved for weight management when appropriate.
Glucophage is generally well tolerated, but side effects can happen. The most common are stomach-related:
Taking Glucophage with meals and increasing the dose gradually may reduce stomach symptoms. Long-term use may lower vitamin B12 levels in some people, so your doctor may check B12, especially if you have anemia, neuropathy symptoms, fatigue, or long-term use.
Rarely, metformin can be associated with lactic acidosis, a serious medical emergency. Risk is higher with severe kidney disease, dehydration, severe infection, low oxygen states, heavy alcohol use, or certain acute illnesses.
Helpful page: diabetes drug safety and side effects.
Seek urgent medical care if you take Glucophage and develop severe weakness, unusual sleepiness, trouble breathing, severe vomiting or diarrhea, dehydration, severe abdominal pain, confusion, chest discomfort, or feeling very cold or unwell. These symptoms need medical evaluation, especially if you have kidney problems or acute illness.
Glucophage can be helpful for people with type 2 diabetes, insulin resistance, and weight concerns, but it should not be presented as a magic weight-loss pill. The best results come when it is used safely with a long-term diabetes care plan.
Educational safety note: This page is for general diabetes education only. It does not replace personal medical advice, diagnosis, or treatment. Do not start, stop, or change Glucophage, metformin, diabetes medicines, supplements, diet, or exercise plans without speaking with your healthcare provider.
Some people lose a small amount of weight on Glucophage, while others maintain weight or notice no change. It is usually weight-neutral or modestly weight-reducing, not a strong weight-loss drug.
Weight loss is usually gradual and may take several weeks or months. Rapid weight loss should be discussed with your doctor.
Only if your healthcare provider prescribes it for a specific reason, such as insulin resistance, prediabetes, or another medical indication. Do not use someone else’s metformin.
It may help reduce insulin resistance and support gradual weight improvement, but belly fat reduction still depends mainly on overall calorie balance, food quality, physical activity, sleep, and metabolic health.
Yes, long-term metformin use may lower vitamin B12 levels in some people. Ask your doctor about B12 testing if you have fatigue, anemia, numbness, tingling, or neuropathy symptoms.
If you live with diabetes, it is understandable to want a simple answer to the question, “What blood sugar should I aim for?”
For many adults, there are well-established treatment targets. However, I always remind my patients that these are general goals, not one-size-fits-all rules. Your safest target depends on your age, type and duration of diabetes, medicines, risk of hypoglycemia, pregnancy status, kidney or heart disease, and overall health.
The goal is not to keep glucose at one perfect number all day. It is to remain within a safe range as consistently as possible while avoiding prolonged high blood sugar and unnecessary low blood sugar.
For many nonpregnant adults with diabetes, commonly used treatment goals are:
| Measurement | Common target | What it means |
|---|---|---|
| Before meals | 80–130 mg/dL (4.4–7.2 mmol/L) |
A common premeal target for many nonpregnant adults |
| Peak after meals | Below 180 mg/dL (below 10.0 mmol/L) |
Usually assessed 1–2 hours after the beginning of the meal |
| A1C | Below 7% (below 53 mmol/mol) |
A common longer-term goal when it can be reached safely |
An acceptable blood glucose level is not necessarily the same as a “normal” glucose level in someone without diabetes.
When we set a diabetes target, we balance two priorities: keeping glucose low enough to reduce the risk of long-term complications while avoiding hypoglycemia and treatment that is too aggressive for the individual patient.
A single blood glucose reading does not provide a complete picture of diabetes control. In clinical practice, I consider the broader pattern, including fasting and premeal glucose levels, post-meal readings when appropriate, A1C, episodes of hypoglycemia, symptoms, current medications, and, when available, continuous glucose monitoring (CGM) data. These measures should also be interpreted in the context of established blood glucose and A1C ranges for normal glucose, prediabetes, and diabetes.
For many nonpregnant adults with diabetes, a common target before meals is 80–130 mg/dL (4.4–7.2 mmol/L).
This gives us useful information about your baseline glucose before food begins to raise it. If most of your premeal readings are within your agreed target, that is encouraging, but they should still be interpreted together with your post-meal pattern, A1C, low-glucose episodes and overall treatment plan.
A reading of 80 mg/dL is not hypoglycemia. It is near the lower end of the usual premeal target. Hypoglycemia is generally defined as glucose below 70 mg/dL.
If fasting or premeal readings are repeatedly above your personal target, possible contributors include overnight glucose production, meal or medication timing, illness, poor sleep, stress and changes in physical activity. A pattern over several days is more informative than one isolated morning reading.
If morning glucose is your main concern, see our guide to fasting blood sugar levels.
For many adults with diabetes, a common target is a peak post-meal glucose below 180 mg/dL (10.0 mmol/L).
When post-meal glucose is being assessed, it is generally measured 1–2 hours after the beginning of the meal. The timing matters because this period is intended to capture glucose near its post-meal peak.
One reading slightly above 180 mg/dL does not necessarily mean your treatment is failing. A larger meal, more carbohydrate than usual, illness, stress, poor sleep or reduced activity can all affect the result. More important questions are whether higher readings occur frequently, remain elevated for a long time, or appear alongside an A1C or CGM pattern showing excessive glucose exposure.
Because blood glucose changes throughout the day, the timing of a measurement matters, particularly when interpreting blood sugar levels after eating.
Daily readings show what your blood sugar is doing at a particular moment. A1C provides a broader view of glucose exposure over the previous two to three months, with more recent weeks contributing more to the result.
For many nonpregnant adults with diabetes, a common A1C goal is below 7% (53 mmol/mol) when it can be achieved safely. Some people may benefit from a lower goal. Others need a less stringent goal because hypoglycemia, frailty, serious comorbidities, cognitive or functional limitations, or treatment burden makes tighter control less safe.
I would not interpret A1C in isolation. Two people can have the same A1C while experiencing very different patterns of highs and lows.
Learn more in A1C vs Blood Sugar, or use our HbA1c to Average Glucose Calculator.
A continuous glucose monitor, or CGM, helps us look beyond individual fingerstick readings. It shows how much time glucose spends within, above and below the target range.
| CGM metric | Common goal for many adults |
|---|---|
| Time in range: 70–180 mg/dL | More than 70% of the time |
| Time below 70 mg/dL | Less than 4% of the time |
| Time below 54 mg/dL | Less than 1% of the time |
| Time above 180 mg/dL | Less than 25% of the time |
CGM goals also need to be individualized. Some older adults with complex health problems, for example, may need more permissive goals to reduce the risk of hypoglycemia.
There is no single bedtime glucose target appropriate for every adult with diabetes. Bedtime goals depend on insulin use, risk of overnight hypoglycemia, age, other medical conditions, recent exercise, meal timing and the treatment plan you follow.
If you use insulin or medicines that can cause hypoglycemia, your clinician may give you a specific bedtime target. Follow that individualized plan rather than relying on a universal bedtime number from the internet.
For people with diabetes, glucose below 70 mg/dL (3.9 mmol/L) is considered hypoglycemia and should be taken seriously. A level below 54 mg/dL (3.0 mmol/L) is more clinically significant.
Symptoms may include shakiness, sweating, hunger, palpitations, dizziness, weakness, irritability, confusion or difficulty concentrating. If you have a hypoglycemia treatment plan, follow it promptly. Frequent low readings require medical review because medication dose, meal timing or activity may need adjustment.
I would not give exactly the same glucose goal to every patient. Your targets may need to be individualized if you:
An older adult who is otherwise healthy may still have relatively tight glucose goals. Someone with frailty, several serious illnesses or recurrent hypoglycemia may need more relaxed targets because preventing low blood sugar becomes the greater priority.
Even when your treatment plan has not changed, glucose can vary from day to day. Common influences include:
This is why I encourage patients to look for patterns rather than reacting strongly to one unusual result.
Keeping glucose in range does not require perfect numbers every day. The practical goal is to make the overall pattern safer and more consistent. Depending on your treatment plan, helpful steps may include:
Do not change insulin or medication doses because of one unusual result unless your healthcare professional has given you a specific adjustment plan.
When a patient asks whether a blood sugar number is “acceptable,” I first ask when it was measured and what target we agreed on for that person.
A premeal glucose of 125 mg/dL may be within the usual target for many adults with diabetes. The same number means something different if we are discussing a fasting laboratory test used to screen a person who has not been diagnosed with diabetes.
I also do not judge diabetes control from one good reading or one bad reading. I want to know whether most values are reasonably close to target, whether there are repeated highs, whether low glucose is occurring, and whether the A1C or CGM report tells the same story.
The best target is not the lowest number you can achieve. It is the range that offers meaningful long-term protection while remaining safe and realistic for your health and treatment.
Contact your healthcare team if:
It depends on when it was measured. For many nonpregnant adults, 130 mg/dL is at the upper end of the common premeal target. After a meal, it may also be within an acceptable range, but your individual target may differ.
For many adults with diabetes, the common goal is a peak post-meal glucose below 180 mg/dL, assessed 1–2 hours after the beginning of the meal. Frequent readings at or above this level should be reviewed as a pattern.
Seventy mg/dL is the threshold at which we become concerned about hypoglycemia. A reading below 70 mg/dL should be treated according to your diabetes plan, and repeated lows should be discussed with your healthcare team.
No. Age, pregnancy, medications, hypoglycemia risk, kidney or heart disease, functional status and other health conditions can all affect the safest goal.
There is no universal bedtime target for every adult with diabetes. Your bedtime goal should reflect your treatment plan, especially if you use insulin or are at risk of overnight hypoglycemia.
No. Below 7% is a common goal for many nonpregnant adults, but some people may benefit from a lower goal and others need a less stringent one for safety.
For many nonpregnant adults with diabetes, common treatment goals are 80–130 mg/dL before meals, below 180 mg/dL at the peak after meals, and A1C below 7% when these goals can be achieved safely.
If you use CGM, spending more than 70% of the time between 70 and 180 mg/dL is a common goal for many adults, while time below 70 mg/dL should remain limited.
Most importantly, your target should fit you. A safe plan balances glucose control with your risk of hypoglycemia, medications, age, other medical conditions and daily life. I would rather see a patient follow a realistic, individualized target safely and consistently than chase a “perfect” number that creates unnecessary risk.
Medical disclaimer: This information is for general education and does not replace professional medical advice, diagnosis or treatment. Follow the glucose targets and treatment plan recommended by your healthcare professional. Do not change insulin or diabetes medication doses without appropriate medical guidance.